Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHVS | AMGN | VRTX | REGN | BMY |
| Company | Pharvaris N.V. | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.27 | 320.08 | 454.17 | 1,011.22 | 54.00 |
| High | 18.53 | 320.21 | 454.36 | 1,011.70 | 54.29 |
| Low | 18.03 | 317.50 | 452.64 | 997.58 | 53.80 |
| Last | 18.20 | 318.95 | 452.99 | 1,000.34 | 54.33 |
| Change | +0.08 | -0.71 | -2.32 | -12.48 | +0.37 |
| % Change | +0.44% | -0.22% | -0.51% | -1.23% | +0.69% |
| Volume | 14,134 | 270,217 | 113,670 | 117,117 | 2,139,685 |
| 20-Day Average Volume | 118,572 | 2,023,132 | 931,676 | 667,723 | 12,725,003 |
| Previous Close | 18.20 | 319.66 | 455.31 | 1,012.82 | 53.96 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.48 | 326.81 | 468.36 | 1,087.61 | 50.77 |
| 20-Day Raw Stochastic | 23.70% | 28.45% | 3.02% | 2.95% | 92.92% |
| 20-Day Relative Strength | 47.55% | 45.35% | 39.89% | 30.95% | 67.92% |
| Weighted Alpha | -19.88 | +13.14 | +18.14 | +14.40 | +4.92 |
| Today's Opinion | 48% Sell | 24% Buy | 8% Buy | 8% Sell | 88% Buy |
| Previous Opinion | 64% Sell | 24% Buy | 8% Buy | 8% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 56% Buy | 40% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.91% since 09/30/24 | -0.73% since 09/30/24 | -2.51% since 09/30/24 | -4.39% since 09/30/24 | +4.48% since 09/30/24 |
| Low | 17.36 on 10/04/24 | 315.46 on 10/03/24 | 452.26 on 10/03/24 | 1,000.11 on 10/07/24 | 51.61 on 10/01/24 |
| High | 18.96 on 10/01/24 | 322.20 on 10/01/24 | 472.31 on 10/01/24 | 1,061.60 on 10/01/24 | 54.54 on 10/02/24 |
| 1-Month | |||||
| %Chg | -4.02% since 09/06/24 | -0.22% since 09/06/24 | -3.12% since 09/06/24 | -11.17% since 09/06/24 | +11.01% since 09/06/24 |
| Low | 17.36 on 10/04/24 | 312.16 on 09/25/24 | 452.26 on 10/03/24 | 1,000.11 on 10/07/24 | 47.55 on 09/09/24 |
| High | 21.54 on 09/10/24 | 339.17 on 09/23/24 | 490.15 on 09/16/24 | 1,170.58 on 09/13/24 | 54.54 on 10/02/24 |
| 3-Month | |||||
| %Chg | +10.21% since 07/05/24 | +2.88% since 07/05/24 | -4.46% since 07/05/24 | -2.81% since 07/05/24 | +36.31% since 07/05/24 |
| Low | 15.50 on 08/09/24 | 306.59 on 08/07/24 | 452.26 on 10/03/24 | 1,000.11 on 10/07/24 | 39.50 on 07/08/24 |
| High | 21.54 on 09/10/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.54 on 10/02/24 |
| 6-Month | |||||
| %Chg | -18.66% since 04/05/24 | +18.48% since 04/05/24 | +11.49% since 04/05/24 | +6.62% since 04/05/24 | +5.34% since 04/05/24 |
| Low | 15.37 on 06/07/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 25.50 on 05/02/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.54 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 579,488 | 171,476,816 | 117,494,112 | 111,598,568 | 109,382,312 |
| Shares Outstanding, K | 31,840 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -109,180,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 12,201,000,000 |
| Last Quarter Net Income | -32,020,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,680,000,000 |
| 60-Month Beta | -3.10 | 0.61 | 0.40 | 0.12 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 08/14/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 11/04/24 | 10/31/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.07 | 0.00 | 26.41 | 39.56 |